(Q34117532)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

obsessive-compulsive disorder

3 November 2019

main subject

0 references

author

Gregory L. Hanna

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

D R Rosenberg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1210-1222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Catechol-O-methyltransferase and Gilles de la Tourette syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Investigation of dopamine system genes in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Basic concepts in the study of diseases with complex genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

The human brain age 7-11 years: a volumetric analysis based on magnetic resonance images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Neurobiology of childhood obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Obsessive compulsive disorder in adolescence: an epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Modified structure of the human serotonin transporter promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Structural abnormalities of frontal neocortex in obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Pharmacotherapy in children and adolescents with obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

The millennium of mind, brain, and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Brain MRI in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Effect of frontal cortex ablation on striatal glutamic acid level in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Mutation screening of human 5-HT(2B)receptor gene in early-onset obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

The 5-HT2B receptor gene maps to 2q36.3-2q37.1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Corpus callosal signal intensity in treatment-naive pediatric obsessive compulsive disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Role of the serotonin transporter promoter polymorphism in anxiety-related traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Frontal cortex and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

A family study of obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

A family study of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Neuroimaging research and the neurobiology of obsessive-compulsive disorder: where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Application of L-glutamic acid and substance P to the substantia nigra modulates in vivo [3H]serotonin release in the basal ganglia of the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Reduced caudate nucleus volume in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Oculomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Assignment of the gene coding for the human high-affinity glutamate transporter EAAC1 to 9p24: potential role in dicarboxylic aminoaciduria and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

9p monosomy in a patient with Gilles de la Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

N-acetylaspartate in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Gene chips and arrays revealed: a primer on their power and their uses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Obsessive-compulsive neurosis: record, follow-up, and family studies. I. Inpatient record study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901073-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)01073-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11137061%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference